HT
CORT icon

HAP Trading’s Corcept Therapeutics CORT Stock Holding History

HAP Trading’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,626
Closed -$2.13M – 772
2025
Q1 		$2.13M Buy
+18,626
New +$1.13M 0.23% 77
2019
Q1 		– Sell
-22,385
Closed -$299K – 1142
2018
Q4 		$299K Buy
+22,385
New +$296K 0.02% 468

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HAP Trading's CORT Position: Q2 2025 in Review

HAP Trading sold out of Corcept Therapeutics (CORT) in Q2 2025, closing a stake of 18,626 shares — an estimated $2.13M sold.

HAP Trading first reported a position in CORT in Q4 2018 and held it in 2 quarters. The position peaked at $2.13M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2025.

  • HAP Trading reported no remaining Corcept Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HAP Trading sold 18,626 Corcept Therapeutics shares in Q2 2025, an estimated $2.13M.
  • HAP Trading first reported a position in Corcept Therapeutics in Q4 2018 and held it in 2 quarters.
  • HAP Trading's Corcept Therapeutics position peaked at $2.13M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2025.

Based on HAP Trading's 13F filing for Q2 2025, filed 13 Aug 2025.